For the Inventor, By the Inventor

Enter assignee name

Fitzroy, Australia

Genetic Technologies Limited

USPTO Granted Patents = 13

% Expired Patents = 76.9

CIPO Patents = 1

EPO Patents = 9

Trademarks = 4

Forward Citations = 35

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Richard Allman (6 out of 9 patents)

Debbie Mantzaris (4 out of 4 patents)

Craig Matthew Lewis (3 out of 7 patents)

4. Eduardo Vom (3 out of 17 patents)

5. David A Hinds (2 out of 4 patents)

6. Ralph Michael Bohmer (2 out of 3 patents)

7. Gillian Sue Dite (1 out of 1 patent)

8. Nicholas Mark Murphy (1 out of 1 patent)

9. Bryan Walser (1 out of 9 patents)

10. Nila Patil (1 out of 5 patents)

11. David R Cox (1 out of 20 patents)

12. Anthony J Berno (1 out of 12 patents)

13. Joseph Frederick Williamson (1 out of 3 patents)

14. John Anthony Millman (1 out of 3 patents)

15. Nicola Charlotte Andrews (1 out of 1 patent)

13 patents: Sort by Forward Citations

1. 11257569 - Methods of assessing risk of developing a severe response to coronavirus infection (2022-02-22),

2. 11072830 - Methods for breast cancer risk assessment (2021-07-27),

3. 11031098 - Computer systems and methods for genomic analysis (2021-06-08),

4. 10920279 - Method for modifying a treatment regimen of a human female subject (2021-02-16),

5. 10683549 - Methods for assessing risk of developing breast cancer (2020-06-16),

6. 9447467 - Methods for obtaining fetal genetic material (2016-09-20),

7. 9078642 - Biological sampling device (2015-07-14),

8. 8827923 - Biological sampling device (2014-09-09),

9. 8734364 - Device and method for obtaining a biological sample (2014-05-27),

10. 8394582 - Identification of fetal DNA and fetal cell markers in maternal plasma or serum (2013-03-12),

11. 8315816 - Methods of genetic analysis involving the amplification of complementary duplicons (2012-11-20),

12. 7785898 - Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood (2010-08-31),

13. 7615342 - ACTN3 genotype screen for athletic performance (2009-11-10),

Genetic Technologies Limited is an Australian biotechnology company focused on the development and commercialization of innovative genetic testing solutions. With expertise in oncology diagnostics, the company's mission is to transform healthcare through personalized genetics. Genetic Technologies offers a range of genetic tests for assessing an individual's risk of developing various genetic diseases, including cancer. Through its cutting-edge technology and partnerships, the company aims to improve patient outcomes by providing early detection and personalized treatment options based on an individual's genetic makeup.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

13 Patents

#1 in Fitzroy

#294 in Australia

#44,950 in the World

Fitzroy, Australia

Genetic Technologies Limited

Forward Citations = 35

19 inventors:

Richard Allman (6 out of 9 patents)

Debbie Mantzaris (4 out of 4 patents)

Craig Matthew Lewis (3 out of 7 patents)

4. Eduardo Vom (3 out of 17 patents)

5. David A Hinds (2 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…